Table of Contents

company-logo

Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate for the treatment of duchenne muscular dystrophy. It also engages in developing of platform technologies, including dual gene expression, a technology for packaging multiple transgenes into one vector, as well as novel capsids. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

Solid Biosciences Dividend Announcement

• Solid Biosciences does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Solid Biosciences dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Solid Biosciences Dividend History

Solid Biosciences Dividend Yield

Solid Biosciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Solid Biosciences stock? Use our calculator to estimate your expected dividend yield:

Solid Biosciences Financial Ratios

P/E ratio-0.24
PEG ratio0.02
P/B ratio0.15
ROE-58.75%
Payout ratio0.00%
Current ratio7.85
Quick ratio7.85
Cash Ratio2.82

Solid Biosciences Dividend FAQ

Does Solid Biosciences stock pay dividends?
Solid Biosciences does not currently pay dividends to its shareholders.
Has Solid Biosciences ever paid a dividend?
No, Solid Biosciences has no a history of paying dividends to its shareholders. Solid Biosciences is not known for its dividend payments.
Why doesn't Solid Biosciences pay dividends?
There are several potential reasons why Solid Biosciences would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Solid Biosciences ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Solid Biosciences has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Solid Biosciences a dividend aristocrat?
Solid Biosciences is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Solid Biosciences a dividend king?
Solid Biosciences is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Solid Biosciences a dividend stock?
No, Solid Biosciences is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Solid Biosciences stocks?
To buy Solid Biosciences you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Solid Biosciences stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.